SCHEMBL20127612

SCHEMBL20127612

c1ccc(-n2c3ccccc3c3cc(-c4c5ccccc5c(-c5ccc6oc7c(ccc8c9ccccc9oc87)c6c5)c5ccccc45)ccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 4/20 0.36
PPARG P37231 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
ALOX5 P09917 1/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 2/20 0.35
BRCA1 P38398 1/20 0.35
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127627 0.96 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL20127626 0.95 KDM4E (0.41) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL1636966 0.94 KDM4E (0.46) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL20127622 0.94 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL1635554 0.92 KDM4E (0.50) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL19465082 0.92 KDM4E (0.50) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL1635568 0.92 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL20127629 0.91 ALOX5 (0.38) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL20321542 0.91 KDM4E (0.44) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL1635804 0.90 KDM4E (0.43) KDM4EATML3MBTL1ALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 KDM4E 4144/4885ATM 3954/4885L3MBTL1 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.